Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05755711 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Study acronym: EMPOWER CAD
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 49 sitesv40
  2. Site details revised at 1 of 49 sitesv39
  3. Primary endpoints revised (2)
    • Secondary endpoints: 12 to 33
    v38
  4. Results first posted: Jan 22, 2026
    • Primary endpoints revised (2)
    • Secondary endpoints expanded, about 89 words
    v37
  5. Site details revised at 1 of 49 sitesv36
Show 34 earlier versionsHide 34 earlier versions
  1. Enrollment target: 400 to 399
    • Primary completion date: Oct 28, 2024 to Dec 11, 2024
    v35
  2. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 50 to 49
    • Primary completion date changed from estimate of Apr 2025 to Oct 28, 2024
    v34
  3. Study sites: 49 to 50v33
  4. Study sites: 47 to 49v32
  5. Study sites: 45 to 47v31
  6. Study sites: 43 to 45v30
  7. Study sites: 42 to 43v29
  8. Site contacts updated at 1 of 42 sitesv28
  9. Study sites: 41 to 42v27
  10. Study sites: 39 to 41v26
  11. Study sites: 38 to 39v25
  12. Study sites: 36 to 38v24
  13. Study sites: 35 to 36v23
  14. Study sites: 34 to 35v22
  15. Study sites: 31 to 34v21
  16. Study sites: 28 to 31v20
  17. Study sites: 27 to 28v19
  18. Study sites: 26 to 27v18
  19. Study sites: 24 to 26v17
  20. Study sites: 23 to 24v16
  21. Study sites: 22 to 23v15
  22. Study sites: 21 to 22v14
  23. Study sites: 19 to 21v13
  24. Study sites: 13 to 19v12
  25. Study sites: 12 to 13v11
  26. Study sites: 10 to 12v10
  27. Study sites: 9 to 10v9
  28. Study sites: 6 to 9v8
  29. Study sites: 4 to 6v7
  30. Study sites: 3 to 4v6
  31. Study sites: 2 to 3v5
  32. Study sites: 1 to 2v4
  33. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  34. Start date: Apr 2023 to May 3, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
Trial Details
NCT Number NCT05755711
Lead Sponsor Shockwave Medical, Inc.
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 399 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov